Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra

Last month, WorldMeds won a historic FDA approval for opioid withdrawal drug Lucemyra, but it needed a marketing partner to help roll it out. Valeant’s Salix has taken the job.